Sanofi said the review of what's called tolebrutinib, to treat non-relapsing secondary progressive multiple sclerosis, will extend beyond Dec. 28, and that it expects further guidance by the U.S. Food ...

Global stock markets were mixed to start the week, with falls across Asia even as European bourses opened up and U.S. stock futures pointed to a modestly higher open. Weak Chinese economic data and ...